191 lines
No EOL
27 KiB
XML
191 lines
No EOL
27 KiB
XML
<?xml version="1.0" encoding="utf-8"?>
|
||
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
|
||
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
|
||
|
||
<head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
|
||
<!-- AppResources meta begin -->
|
||
<meta name="paf-app-resources" content="" />
|
||
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
||
|
||
<!-- AppResources meta end -->
|
||
|
||
<!-- TemplateResources meta begin -->
|
||
<meta name="paf_template" content="" />
|
||
|
||
<!-- TemplateResources meta end -->
|
||
|
||
<!-- Logger begin -->
|
||
<meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK501541" /><meta name="ncbi_domain" content="lactmed" /><meta name="ncbi_report" content="printable" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK501541/?report=printable" /><meta name="ncbi_app" content="bookshelf" />
|
||
<!-- Logger end -->
|
||
|
||
<title>Ritonavir - Drugs and Lactation Database (LactMed®) - NCBI Bookshelf</title>
|
||
|
||
<!-- AppResources external_resources begin -->
|
||
<link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>
|
||
|
||
<!-- AppResources external_resources end -->
|
||
|
||
<!-- Page meta begin -->
|
||
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="Drugs and Lactation Database (LactMed®) [Internet]" /><meta name="citation_title" content="Ritonavir" /><meta name="citation_publisher" content="National Institute of Child Health and Human Development" /><meta name="citation_date" content="2024/07/15" /><meta name="citation_pmid" content="30000601" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK501541/" /><meta name="citation_keywords" content="ritonavir" /><meta name="citation_keywords" content="Norvir" /><meta name="citation_keywords" content="Kaletra" /><meta name="citation_keywords" content="Viekira" /><meta name="citation_keywords" content="ABT-538" /><meta name="citation_keywords" content="Abbott 84538" /><meta name="citation_keywords" content="ABBOTT-84538" /><meta name="citation_keywords" content="A-84538" /><meta name="citation_keywords" content="UNII-O3J8G9O825" /><meta name="citation_keywords" content="TMC 114r" /><meta name="citation_keywords" content="DRG-0244" /><meta name="citation_keywords" content="HSDB 7160" /><meta name="citation_keywords" content="O3J8G9O825" /><meta name="citation_keywords" content="RTV" /><meta name="citation_keywords" content="5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate" /><meta name="citation_keywords" content="5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate" /><meta name="citation_keywords" content="2,4,7,12-Tetraazatridecan-13-oic acid, 10-hydroxy-2-methyl-5-(1-methylethyl)-1-(2-(1-methylethyl)-4-thiazolyl)-3,6-dioxo-8,11-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (5S-(5R*,8R*,10R*,11R*))-" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Ritonavir" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Institute of Child Health and Human Development" /><meta name="DC.Date" content="2024/07/15" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK501541/" /><meta name="description" content="Ritonavir is excreted into milk in measurable concentrations and low levels can be found in the blood of some breastfed infants. No adverse reactions in breastfed infants have been reported. Achieving and maintaining viral suppression with antiretroviral therapy decreases breastfeeding transmission risk to less than 1%, but not zero. Individuals with HIV who are on antiretroviral therapy with a sustained undetectable viral load and who choose to breastfeed should be supported in this decision. If a viral load is not suppressed, banked pasteurized donor milk or formula is recommended.[1,2]" /><meta name="og:title" content="Ritonavir" /><meta name="og:type" content="book" /><meta name="og:description" content="Ritonavir is excreted into milk in measurable concentrations and low levels can be found in the blood of some breastfed infants. No adverse reactions in breastfed infants have been reported. Achieving and maintaining viral suppression with antiretroviral therapy decreases breastfeeding transmission risk to less than 1%, but not zero. Individuals with HIV who are on antiretroviral therapy with a sustained undetectable viral load and who choose to breastfeed should be supported in this decision. If a viral load is not suppressed, banked pasteurized donor milk or formula is recommended.[1,2]" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK501541/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-lactmed-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/lactmed/LM650/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK501541/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_print.min.css" type="text/css" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} </style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/books.min.js"> </script>
|
||
|
||
<!-- Page meta end -->
|
||
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B17697D8345310000000000A00091.m_5" />
|
||
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4216701/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3984801/12930/3964959.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3411343/3882866.css" media="print" /></head>
|
||
<body class="book-part">
|
||
<div class="grid no_max_width">
|
||
<div class="col twelve_col nomargin shadow">
|
||
<!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
|
||
<div class="sysmessages">
|
||
<noscript>
|
||
<p class="nojs">
|
||
<strong>Warning:</strong>
|
||
The NCBI web site requires JavaScript to function.
|
||
<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
|
||
</p>
|
||
</noscript>
|
||
</div>
|
||
<!--/.sysmessage-->
|
||
<div class="wrap">
|
||
<div class="page">
|
||
<div class="top">
|
||
|
||
<div class="header">
|
||
|
||
|
||
</div>
|
||
|
||
|
||
|
||
<!--<component id="Page" label="headcontent"/>-->
|
||
|
||
</div>
|
||
<div class="content">
|
||
<!-- site messages -->
|
||
<div class="container content">
|
||
<div class="document">
|
||
<div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-. </p></div></div></div>
|
||
<div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK501541_"><span class="title" itemprop="name">Ritonavir</span></h1><p class="small">Last Revision: <span itemprop="dateModified">July 15, 2024</span>.</p><p><em>Estimated reading time: 5 minutes</em></p></div><div class="body-content whole_rhythm" itemprop="text"><p>CASRN: 155213-67-5</p><a href="https://pubchem.ncbi.nlm.nih.gov/substance/135017420" title="View this structure in PubChem" class="img_link" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem"><img src="https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=l&sid=135017420" alt="image 135017420 in the ncbi pubchem database" /></a><div id="LM650.Drug_Levels_and_Effects"><h2 id="_LM650_Drug_Levels_and_Effects_">Drug Levels and Effects</h2><div id="LM650.Summary_of_Use_during_Lactation"><h3>Summary of Use during Lactation</h3><p>Ritonavir is excreted into milk in measurable concentrations and low levels can be found in the blood of some breastfed infants. No adverse reactions in breastfed infants have been reported. Achieving and maintaining viral suppression with antiretroviral therapy decreases breastfeeding transmission risk to less than 1%, but not zero. Individuals with HIV who are on antiretroviral therapy with a sustained undetectable viral load and who choose to breastfeed should be supported in this decision. If a viral load is not suppressed, banked pasteurized donor milk or formula is recommended.[<a class="bk_pop" href="#LM650.REF.1">1</a>,<a class="bk_pop" href="#LM650.REF.2">2</a>]</p></div><div id="LM650.Drug_Levels"><h3>Drug Levels</h3><p><i>Maternal Levels.</i> One study measured ritonavir in breastmilk samples from nursing mothers who had been randomized to receive the drug as part of a clinical trial to evaluate maternal-to-child transmission of HIV infection. The dosages, dosage regimens and times of breastmilk sample collection times were not reported. Ritonavir was not detected in any of 60 breastmilk samples.[<a class="bk_pop" href="#LM650.REF.3">3</a>]</p><p>Nine mothers who were receiving lopinavir 400 mg plus ritonavir 100 mg twice daily as part of a combination antiretroviral regimen provided a total of 23 milk samples at birth, 1 month, 3 months and/or 6 months postpartum. Milk samples were collected at a median of 4.5 hours (range 3.5 to 6 hours) after the previous dose. The median breastmilk ritonavir concentration was 79 mcg/L (range 31 to 193 mcg/L).[<a class="bk_pop" href="#LM650.REF.4">4</a>]</p><p>Thirty women were studied at 6, 12 or 24 weeks postpartum (10 at each time). Each mother was taking zidovudine 300 mg, lamivudine 150 mg, lopinavir 400 mg, and ritonavir 100 mg twice daily by mouth starting at delivery. On the study day, at a median of 14.9 hours after the previous evening's dose, maternal plasma and breastmilk samples were obtained prior to the morning dose and 2, 4 and 6 hours after the dose. One hundred twelve of the 121 breastmilk samples contained detectable quantities (10 mcg/L or greater) of ritonavir, with a median breastmilk concentration of 79 mcg/L over the 6 hours.[<a class="bk_pop" href="#LM650.REF.5">5</a>]</p><p>Nine HIV-positive women about to undergo cesarean section received 3 doses of lopinavir 200 mg, ritonavir 150 mg, zidovudine 300 mg, lamivudine 50 mg at 3 hour intervals before the procedure. Breastmilk samples were collected at a mean of 25 hours postpartum. In the 8 women where it was quantified, the average milk concentration of ritonavir was 240 mcg/L (range 98 to 402 mcg/L).[<a class="bk_pop" href="#LM650.REF.6">6</a>]</p><p>Eight women who were taking nirmatrelvir-ritonavir and had donated milk samples to a breastmilk repository had their milk analyzed for nirmatrelvir. All were taking a ritonavir dose of 100 mg twice daily and reported taking milk samples at 0, 1, 2, 4, 6, 8, 10, and 12 hours after a dose. The peak ritonavir concentration in milk occurred at 4 hours after the dose was 55.6 mcg/L and the average concentration was 33.5 mcg/L. This translated into a daily infant dose of 0.005 mg/kg or a relative infant dose of 0.19%.[<a class="bk_pop" href="#LM650.REF.7">7</a>]</p><p><i>Infant Levels.</i> Breastfed infants of 9 mothers who were receiving lopinavir 400 mg plus ritonavir 100 mg twice daily as part of a combination antiretroviral regimen had a total of 6 blood samples analyzed at 1 month, 3 months and/or 6 months postpartum. Samples were collected at a median of 4.5 hours (range 3.5 to 6 hours) after the previous maternal dose and a median of 30 minutes (range 20 to 60 minutes) after the previous nursing. The infants' median ritonavir plasma concentration was 7 mcg/L (range 0 to 138 mcg/L), which was a median of 12% (range 11 to 40%) of the maternal serum concentration.[<a class="bk_pop" href="#LM650.REF.4">4</a>]</p><p>Ritonavir was measured in 117 breastfed (90% exclusive) infants whose mothers were taking lopinavir plus ritonavir for HIV infection during pregnancy and postpartum. At 8 and 12 weeks postpartum, none of the infants had detectable ritonavir in their plasma; 91% of infants had detectable ritonavir in their hair samples at 12 weeks postpartum at a mean concentration of 0.15 ng/mg of hair (range 0.03 to 0.42 ng/mg). The authors interpreted the results to mean that infants receive negligible exposure to ritonavir during breastfeeding.[<a class="bk_pop" href="#LM650.REF.8">8</a>]</p><p>Thirty nursing mothers were studied at 6, 12 or 24 weeks postpartum (10 at each time). Each mother was taking ritonavir 100 mg twice daily by mouth starting at delivery. Infant plasma samples were obtained before their mother's first dose and at 2, 4 and 6 hours after the mother's dose. Infants were allowed to breastfeed <i>ad libitum</i> during the study period. Ritonavir was undetectable (<10 mcg/L) in all of the 115 infant plasma samples.[<a class="bk_pop" href="#LM650.REF.5">5</a>]</p></div><div id="LM650.Effects_in_Breastfed_Infants"><h3>Effects in Breastfed Infants</h3><p>Relevant published information was not found as of the revision date.</p></div><div id="LM650.Effects_on_Lactation_and_Breastmil"><h3>Effects on Lactation and Breastmilk</h3><p>Gynecomastia has been reported among men receiving highly active antiretroviral therapy. Gynecomastia is unilateral initially, but progresses to bilateral in about half of cases. No alterations in serum prolactin were noted and spontaneous resolution usually occurred within one year, even with continuation of the regimen.[<a class="bk_pop" href="#LM650.REF.9">9</a>-<a class="bk_pop" href="#LM650.REF.11">11</a>] Some case reports and in vitro studies have suggested that protease inhibitors might cause hyperprolactinemia and galactorrhea in some male patients,[<a class="bk_pop" href="#LM650.REF.12">12</a>,<a class="bk_pop" href="#LM650.REF.13">13</a>] although this has been disputed.[<a class="bk_pop" href="#LM650.REF.14">14</a>] The relevance of these findings to nursing mothers is not known. The prolactin level in a mother with established lactation may not affect her ability to breastfeed.</p></div><div id="LM650.References"><h3>References</h3><dl class="temp-labeled-list"><dt>1.</dt><dd><div class="bk_ref" id="LM650.REF.1">World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: Recommendations for a public health approach. 2021.<a href="https://www.who.int/publications/i/item/9789240031593" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">https://www<wbr style="display:inline-block"></wbr>.who.int/publications<wbr style="display:inline-block"></wbr>/i/item/9789240031593</a> [<a href="https://pubmed.ncbi.nlm.nih.gov/34370423" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 34370423</span></a>]</div></dd><dt>2.</dt><dd><div class="bk_ref" id="LM650.REF.2">Department of Health and Human Services. Recommendations for the use of antiretroviral drugs during pregnancy and interventions to reduce perinatal HIV transmission in the United States. 2024.<a href="https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/perinatal-hiv/guidelines-perinatal.pdf" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">https:<wbr style="display:inline-block"></wbr>//clinicalinfo<wbr style="display:inline-block"></wbr>.hiv.gov/sites/default<wbr style="display:inline-block"></wbr>/files/guidelines/documents<wbr style="display:inline-block"></wbr>/perinatal-hiv<wbr style="display:inline-block"></wbr>/guidelines-perinatal.pdf</a></div></dd><dt>3.</dt><dd><div class="bk_ref" id="LM650.REF.3">Rezk
|
||
NL, White
|
||
N, Bridges
|
||
AS, et al.
|
||
Studies on antiretroviral drug concentrations in breast milk: Validation of a liquid chromatography-tandem mass spectrometric method for the determination of 7 anti-human immunodeficiency virus medications.
|
||
Ther Drug Monit
|
||
2008;30:611-9
|
||
[<a href="/pmc/articles/PMC2901847/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC2901847</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18758393" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 18758393</span></a>]</div></dd><dt>4.</dt><dd><div class="bk_ref" id="LM650.REF.4">Palombi
|
||
L, Pirillo
|
||
MF, Andreotti
|
||
M, et al.
|
||
Antiretroviral prophylaxis for breastfeeding transmission in Malawi: drug concentrations, virological efficacy and safety.
|
||
Antivir Ther
|
||
2012;17:1511-9
|
||
[<a href="https://pubmed.ncbi.nlm.nih.gov/22910456" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 22910456</span></a>]</div></dd><dt>5.</dt><dd><div class="bk_ref" id="LM650.REF.5">Corbett
|
||
AH, Kayira
|
||
D, White
|
||
NR, et al.
|
||
Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post-partum: Results of the BAN Study.
|
||
Antivir Ther
|
||
2014;19:587-95
|
||
[<a href="/pmc/articles/PMC4110187/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4110187</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24464632" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24464632</span></a>]</div></dd><dt>6.</dt><dd><div class="bk_ref" id="LM650.REF.6">Ramírez-Ramírez
|
||
A, Sanchez-Serrano
|
||
E, Loaiza-Flores
|
||
G, et al.
|
||
Simultaneous quantification of four antiretroviral drugs in breast milk samples from HIV-positive women by an ultra-high performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method.
|
||
PLoS One
|
||
2018;13:e0191236
|
||
[<a href="/pmc/articles/PMC5774716/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5774716</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29351333" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 29351333</span></a>]</div></dd><dt>7.</dt><dd><div class="bk_ref" id="LM650.REF.7">Dai
|
||
J, Fuquay
|
||
T, Huseman
|
||
S, et al.
|
||
Low nirmatrelvir and ritonavir exposure through breastmilk: Analyzing milk concentrations and infant risk.
|
||
Clin Pharmacol Ther
|
||
2024
|
||
[<a href="https://pubmed.ncbi.nlm.nih.gov/38923506" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 38923506</span></a>]</div></dd><dt>8.</dt><dd><div class="bk_ref" id="LM650.REF.8">Gandhi
|
||
M, Mwesigwa
|
||
J, Aweeka
|
||
F, et al.
|
||
Hair and plasma data show that lopinavir, ritonavir, and efavirenz all transfer from mother to infant in utero, but only efavirenz transfers via breastfeeding.
|
||
J Acquir Immune Defic Syndr
|
||
2013;63:578-84
|
||
[<a href="/pmc/articles/PMC3800282/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3800282</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24135775" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24135775</span></a>]</div></dd><dt>9.</dt><dd><div class="bk_ref" id="LM650.REF.9">García-Benayas
|
||
T, Blanco
|
||
F, Martin-Carbonero
|
||
L, et al.
|
||
Gynecomastia in HIV-infected patients receiving antiretroviral therapy.
|
||
AIDS Res Hum Retroviruses
|
||
2003;19:739-41
|
||
[<a href="https://pubmed.ncbi.nlm.nih.gov/14585204" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 14585204</span></a>]</div></dd><dt>10.</dt><dd><div class="bk_ref" id="LM650.REF.10">Pantanowitz
|
||
L, Evans
|
||
D, Gross
|
||
PD, et al.
|
||
HIV-related gynecomastia.
|
||
Breast J
|
||
2003;9:131-2
|
||
[<a href="https://pubmed.ncbi.nlm.nih.gov/12603389" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12603389</span></a>]</div></dd><dt>11.</dt><dd><div class="bk_ref" id="LM650.REF.11">Evans
|
||
DL, Pantanowitz
|
||
L, Dezube
|
||
BJ, et al.
|
||
Breast enlargement in 13 men who were seropositive for human immunodeficiency virus.
|
||
Clin Infect Dis
|
||
2002;35:1113-9
|
||
[<a href="https://pubmed.ncbi.nlm.nih.gov/12384846" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12384846</span></a>]</div></dd><dt>12.</dt><dd><div class="bk_ref" id="LM650.REF.12">Hutchinson
|
||
J, Murphy
|
||
M, Harries
|
||
R, et al.
|
||
Galactorrhoea and hyperprolactinaemia associated with protease-inhibitors.
|
||
Lancet
|
||
2000;356:1003-4
|
||
[<a href="https://pubmed.ncbi.nlm.nih.gov/11041407" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11041407</span></a>]</div></dd><dt>13.</dt><dd><div class="bk_ref" id="LM650.REF.13">Orlando
|
||
G, Brunetti
|
||
L, Vacca
|
||
M. Ritonavir and saquinavir directly stimulate anterior pituitary prolactin secretion, in vitro.
|
||
Int J Immunopathol Pharmacol
|
||
2002;15:65-8
|
||
[<a href="https://pubmed.ncbi.nlm.nih.gov/12593790" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12593790</span></a>]</div></dd><dt>14.</dt><dd><div class="bk_ref" id="LM650.REF.14">Montero
|
||
A, Bottasso
|
||
OA, Luraghi
|
||
MR, et al.
|
||
Galactorrhoea, hyperprolactinaemia, and protease inhibitors.
|
||
Lancet
|
||
2001;357:473-5
|
||
[<a href="https://pubmed.ncbi.nlm.nih.gov/11273087" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11273087</span></a>]</div></dd></dl></div></div><div id="LM650.Substance_Identification"><h2 id="_LM650_Substance_Identification_">Substance Identification</h2><div id="LM650.Substance_Name"><h3>Substance Name</h3><p>Ritonavir</p></div><div id="LM650.CAS_Registry_Number"><h3>CAS Registry Number</h3><p>155213-67-5</p></div><div id="LM650.Drug_Class"><h3>Drug Class</h3><p>Breast Feeding</p><p>Lactation</p><p>Milk, Human</p><p>Anti-Infective Agents</p><p>Antiviral Agents</p><p>Anti-HIV Agents</p><p>Anti-Retroviral Agents</p><p>HIV Protease Inhibitors</p></div></div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_top_margin"><p><b>Disclaimer: </b>Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.</p></p></div></dd></dl></div><div id="bk_toc_contnr"></div></div></div>
|
||
<div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a><p class="small"><b>Attribution Statement:</b> LactMed is a registered trademark of the U.S. Department of Health and Human Services.</p></div><div class="small"><span class="label">Bookshelf ID: NBK501541</span><span class="label">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30000601" title="PubMed record of this page" ref="pagearea=meta&targetsite=entrez&targetcat=link&targettype=pubmed">30000601</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/lactmed/">Contents</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/lactmed/ritlecitinib/" title="Previous page in this title">< Prev</a><a class="active page_link next" href="/books/n/lactmed/LM888/" title="Next page in this title">Next ></a></div></div></div></div>
|
||
|
||
</div>
|
||
</div>
|
||
</div>
|
||
<div class="bottom">
|
||
|
||
<div id="NCBIFooter_dynamic">
|
||
<!--<component id="Breadcrumbs" label="breadcrumbs"/>
|
||
<component id="Breadcrumbs" label="helpdesk"/>-->
|
||
|
||
</div>
|
||
|
||
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
|
||
</div>
|
||
</div>
|
||
<!--/.page-->
|
||
</div>
|
||
<!--/.wrap-->
|
||
</div><!-- /.twelve_col -->
|
||
</div>
|
||
<!-- /.grid -->
|
||
|
||
<span class="PAFAppResources"></span>
|
||
|
||
<!-- BESelector tab -->
|
||
|
||
|
||
|
||
<noscript><img alt="statistics" src="/stat?jsdisabled=true&ncbi_db=books&ncbi_pdid=book-part&ncbi_acc=NBK501541&ncbi_domain=lactmed&ncbi_report=printable&ncbi_type=fulltext&ncbi_objectid=&ncbi_pcid=/NBK501541/?report=printable&ncbi_app=bookshelf" /></noscript>
|
||
|
||
|
||
<!-- usually for JS scripts at page bottom -->
|
||
<!--<component id="PageFixtures" label="styles"></component>-->
|
||
|
||
|
||
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal104 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
||
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
||
|
||
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3879255/4121861/3501987/4008961/3893018/3821238/3400083/3426610.js" snapshot="books"></script></body>
|
||
</html> |